Stay updated on Ligelizumab in CSU Adolescents & Adults Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in CSU Adolescents & Adults Clinical Trial page.

Latest updates to the Ligelizumab in CSU Adolescents & Adults Clinical Trial page
- Check7 days agoChange DetectedThe site’s revision tag was updated from v3.6.3 to v3.6.4, indicating a software version update.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.3, indicating a small update to the page or its metadata without changing core study details.SummaryDifference0.0%

- Check49 days agoChange DetectedRecruitment status updated to not recruiting participants, and new guidance sections added to help readers navigate and understand the study record; a heading refinement and a revision note accompany the update.SummaryDifference0.2%

- Check56 days agoChange DetectedThe Revision line was updated from v3.5.4 to v3.5.5, reflecting a minor version update to the page's metadata.SummaryDifference0.0%

- Check78 days agoChange DetectedThe site's revision tag was updated from v3.5.3 to v3.5.4, indicating a deployment of software updates to the ClinicalTrials.gov interface. This is a technical version change and does not modify the study data or content displayed on the page.SummaryDifference0.0%

- Check92 days agoChange DetectedThe Taiwan site location in the study locations was updated from Taoyuan District to Taoyuan, Taiwan, 33305, indicating a shift to the city-level designation while preserving the same postal code.SummaryDifference0.0%

Stay in the know with updates to Ligelizumab in CSU Adolescents & Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in CSU Adolescents & Adults Clinical Trial page.